Patients with ankylosing spondylitis and IBD exhibit distinct clinical and radiographic features, compared against those without comorbid IBD.

AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030.

Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study ...

Eli Lilly achieved the largest market capitalisation growth of 32.4% to $733bn in 2024, driven by strong demand for Mounjaro ...

A project based in a Nottinghamshire town is helping the community by getting young people hooked on fishing. Mending Lines ...

The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.

Ankylosing Spondylitis (AS) is a chronic inflammatory arthritis that predominantly affects the axial skeleton in adolescent patients causing spinal pain and stiffness. There is a marked delay ...

The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...

The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...

Alvotech and Teva announced FDA acceptance of the Biologics License Application (BLA) for AVT05, a proposed biosimilar ...

Ageing is a natural and unavoidable phenomenon that brings with it various health challenges, including arthritis, memory ...

(9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been accepted by ...